The Lyceum: Sunday Edition — Mar 22, 2026

This was the week the war stopped being something happening "over there." A 48-hour ultimatum, a missile that damaged areas near Israel's most protected nuclear zone, oil above $110 at session highs, and a helium shortage quietly threatening the chips in your phone — the second-order consequences of a conflict now in its fourth week are outrunning the headlines. Meanwhile, a jury told the world's richest man he committed fraud, fifty nations tried to write rules for AI, and a cholesterol pill that could rival statins got buried under everything else.

On Saturday, President Trump posted a public ultimatum on Truth Social: Iran has until Monday evening to reopen the Strait of Hormuz — the 21-mile gap between Iran and Oman through which roughly 20% of the world's oil transits — or the United States will "hit and obliterate" Iranian power plants. That deadline expires Monday evening — roughly 36 hours from publication. As of Sunday morning, no strike has occurred, but the ultimatum has already reshaped weekend diplomacy and markets in real time.

The ultimatum landed amid a week of escalation that erased any remaining illusion this conflict would stay contained. On March 21, Iranian missiles damaged areas near Dimona, the city that houses Israel's primary nuclear research facility, injuring more than 100 people — the first time an attack appears to have penetrated that heavily defended zone. Separately, Iran launched two intermediate-range ballistic missiles at Diego Garcia, the joint U.S.-UK base in the Indian Ocean thousands of kilometers from the theater. Both reportedly missed, but the reach alone signals capabilities Western planners hadn't fully priced in.

In a Senate floor vote on March 21, a War Powers resolution requiring congressional authorization for continued military action failed 47–53 — not enough to pass. Thirteen U.S. service members are dead. Over 230 are wounded. The Pentagon is seeking $200 billion in supplemental war funding.

What changes if this escalates: striking Iran's power grid would affect 85 million civilians and could prompt retaliatory attacks on U.S. and allied energy infrastructure — Iran has explicitly warned as much. The observable signal is simple: watch oil prices Monday morning. If Brent gaps above $120 at the open, markets have concluded the strikes are coming. If it pulls back, traders think diplomacy bought time. Either way, the Strait remains effectively closed, and the economic damage compounds daily.

The war arrived at your gas pump this week. Brent crude topped $112 per barrel at session highs after Iranian drones damaged Kuwait's Mina Al-Ahmadi refinery on March 21 — the second attack on that facility in days. Oil prices have now risen roughly 45% since the conflict began.

The U.S. national average for a gallon of gas climbed to about $3.91, up nearly a dollar since fighting started. Markets buckled under the weight. The S&P 500 fell 1.5% on the session on Friday to close at 6,506.48, its fourth consecutive weekly loss. The Nasdaq dropped 2% on the session on Friday. The Russell 2000, home to smaller, rate-sensitive companies, slipped into correction territory. The Federal Reserve held rates at 3.5–3.75% and signaled no cuts this year — a stance that made sense before the war but now collides with an energy shock that typically feeds into inflation data two to four months later. The Bank of England was blunter, warning inflation could reach 5% on a 12-month basis if energy prices persist; UK mortgage rates have already jumped nearly half a percentage point in March alone.

The stress isn't just macro. Alibaba and Tencent lost a combined $66 billion in market value on the week amid AI strategy skepticism. Nvidia fell amid regulatory scrutiny of its $20 billion Groq acquisition. And the Super Micro indictment (more below) rattled AI hardware supply chains at exactly the wrong moment.

If oil breaks decisively above $120 and stays there, central banks face an impossible choice: hold rates and risk recession, or cut and risk embedding inflation. The signal to watch is whether the Fed's upcoming speakers lean hawkish on re-anchoring inflation expectations — if they do, bond yields and mortgage rates jump even without a rate move.

This is the war story nobody's talking about, and it might matter more to your daily life than the Strait of Hormuz. Helium — yes, the gas in party balloons — is irreplaceable in semiconductor manufacturing. Chipmakers blow it over silicon wafers during etching to keep temperatures precisely stable. There is no effective substitute.

Qatar supplies a third of the world's helium. A drone strike damaged a QatarEnergy facility this week, and after additional Iranian strikes hit the Ras Laffan complex, QatarGas reported "extensive" damage that will take years to repair and cut annual helium exports by 14%. Spot prices have already doubled since the war began, according to the AP. South Korea — home to Samsung and SK Hynix, the world's largest memory chipmakers — imports about 65% of its helium from Qatar, per a Fitch Ratings report cited by Fortune.

"Your best case scenario would be you're back producing some helium in six weeks or something like that. As it looks right now, that's highly unlikely," Phil Kornbluth, president of Kornbluth Helium Consulting, told the Boston Globe. TSMC and SK Hynix say they have months of inventory. That buys time, but not indefinitely — and Le Monde reports the pattern of attacks on Gulf energy facilities is intensifying, not stabilizing.

If helium shortages start biting fabs in Q3, expect delivery delays on everything from AI servers to consumer electronics — and watch industrial gas supplier Linde, which JPMorgan, Deutsche Bank, and Wells Fargo have all flagged as a beneficiary. This is the war's clearest hidden fingerprint on the AI buildout.

The Foreign Policy Research Institute published a detailed analysis this week that deserves more attention than a Reddit thread can give it. In the first 96 hours of the Iran conflict, the U.S.-led coalition expended approximately 5,197 munitions across 35 types — carrying a replacement bill of $10–$16 billion in just four days.

The deeper problem isn't the quantity — it's the industrial plumbing. The high explosives that fill American warheads, RDX and HMX, flow through a single facility: the Holston Army Ammunition Plant in Kingsport, Tennessee, operated by BAE Systems. There is no second domestic source. As of March 12, Holston had not received orders to increase production despite the war.

Meanwhile, Secretary of State Rubio handed Iran's strategists a useful data point: Iran is "producing, by some estimates, over 100 of these missiles a month. Compare that to the six or seven interceptors that can be built a month," according to CNN. The asymmetry is the whole strategy — cheap drones and missiles that demand million-dollar interceptors in response. Washington entered month one of this war without a clear answer to that equation.

If the conflict extends past spring, the signal to watch is whether the Pentagon activates Defense Production Act authorities for munitions — that would mean the math has gotten bad enough to override peacetime procurement norms.

On March 21, a federal jury in San Francisco ruled that Elon Musk misled shareholders by misrepresenting Twitter's fake account numbers before his $44 billion acquisition in 2022. The verdict — reported by NPR, OPB, and CNBC — found liability on a per-share-per-day basis that plaintiffs' lawyers estimate will total roughly $2.1 billion. Musk's team says they will appeal.

This isn't just expensive for Musk — it's precedent-setting. The verdict tells every executive considering a public acquisition that misleading investors about a target company's metrics can produce personal liability measured in billions. The damages phase, where a judge translates the jury's framework into a final dollar figure, will be closely watched by securities lawyers and corporate boards.

If the appeal fails and damages hold near the estimated range, it means the legal system can impose real costs on billionaires who treat disclosure obligations as optional. If the appeal succeeds or damages shrink dramatically, it means the existing enforcement framework still struggles with concentrated wealth and aggressive legal teams. Watch for the appeal filing timeline and whether any institutional investors use this verdict to push for stronger disclosure rules.

The New England Journal of Medicine published Phase 3 trial data this week for enlicitide, an oral drug that reduced LDL cholesterol by about 60% at one year — matching the potency of injectable therapies that most patients never receive because, well, they're injections. The trial, sponsored by Merck, enrolled roughly 2,900 patients across 168 sites in 14 countries and showed sustained reductions over a full year with a safety profile described as comparable to placebo.

Why this matters beyond cardiology: existing injectable PCSK9 inhibitors already work this well, but the vast majority of primary care physicians still don't prescribe them, largely because they require regular shots. A pill changes the compliance calculus entirely. The lead researcher at UT Southwestern called these results "the most we have ever achieved with an oral drug by far since the development of statins" — and statins became one of the most prescribed medications in human history.

The important caveat: durability and actual cardiovascular event reduction remain unproven pending the CORALreef Outcomes trial, which runs through 2029. This is a Phase 3 efficacy result, not a finished story. But if approval follows and uptake matches the convenience advantage, this is a statin-scale moment for heart disease — and it got buried under missiles.

At the Global AI Regulation Summit in Geneva, concluding March 19, fifty countries agreed to a binding framework requiring companies to disclose how their "agentic" AI systems — software that can plan and act autonomously — make decisions, with a 2028 compliance deadline. Over 200 tech firms pledged to comply. The EU and China co-led the negotiations, an unusual alignment that gives the framework real geopolitical weight.

Domestically, the White House released a National AI Legislation Framework the same week, calling for federal preemption of state AI laws, liability limits for developers, and child-safety protections. Meanwhile, Anthropic filed suit challenging a Trump administration "supply chain risk" designation that effectively bars it from government contracts — apparently linked to the company's refusal to build autonomous weapons. It's the first major legal challenge by an AI firm to that type of classification.

The interesting fault line isn't between countries — it's between AI companies that think binding rules entrench well-resourced incumbents and smaller developers who think accountability is overdue. If the EU and China remain aligned on enforcement, this becomes the de facto global standard whether Washington formally endorses it or not. If enforcement proves toothless — no fines, no blocked deployments — the framework becomes decorative. The signal: watch whether any major firm faces a penalty or contract loss under these rules before 2028.

A Fox News story highlights a Republican senator’s effort to challenge Democratic claims about their support for voter ID laws, presenting examples the senator says show Democrats have misled the public. The piece focuses on the senator’s public gambit and the political fallout for both parties as they position on election rules.

Also in right-leaning news:

• Former FBI director Robert Mueller has died at 81, reports the Wall Street Journal.
• Fox News reports on a viral ‘blackout challenge’ that killed a 9‑year‑old and the ensuing calls for accountability.

Slate examines a relatively obscure Supreme Court case it says could be used to advance Trump-era voting restrictions by creating a legal pathway for changes that weaken voter protections. The article explains the legal theory at issue and sketches how a decision for the petitioners might affect national election rules.

Also in progressive news:

• The Guardian reports that Trump is willing to share others’ medical details while resisting disclosure about his own health.
• Vox profiles a high-profile investor whose bet against major global trends has largely failed.

Voting rules and voter suppression. Two treatments. Same facts, genuinely different emphasis. Which perspective is which?

Version A

The debate over voter identification laws has long been distorted by a rhetorical sleight of hand: the conflation of reasonable administrative requirements with deliberate disenfranchisement. When Senate Republicans recently forced a procedural vote on voter ID legislation, the maneuver revealed something instructive — many Democratic colleagues who publicly endorse the principle of voter ID in polling found reasons to oppose the specific measure. This is not a trivial inconsistency. Roughly 80 percent of Americans across racial and partisan lines support some form of identification requirement at the polls, a figure that has remained stable for years. The conservative case for voter ID rests not on suspicion of any particular community but on the same logic that underlies signature verification, chain-of-custody documentation, and audit trails in every other domain of civic life. Elections derive their legitimacy from public confidence, and public confidence requires verifiable process. The burden, properly understood, falls on election administrators to make compliant ID accessible — a goal most voter ID proposals explicitly include — not on citizens to accept an honor system for the franchise.

Version B

The Supreme Court case now drawing quiet attention from election-law scholars — a challenge touching on the independent state legislature doctrine and federal preclearance requirements — may matter far more than the louder congressional fights over voter ID. What makes this moment consequential is not any single bill but the accumulating architecture: documentary proof-of-citizenship requirements that the Government Accountability Office has linked to measurable drops in registration among eligible voters, aggressive voter-roll purges conducted under methodologies courts have repeatedly questioned, and the systematic closure of polling locations concentrated in high-density, majority-minority precincts. These are not hypothetical harms. They are documented patterns with documented disparate effects. The progressive concern is not that election integrity is an illegitimate value — it plainly is not — but that the specific mechanisms being advanced impose costs that fall unequally along lines of race and class, and that the judicial pathways being explored could insulate those mechanisms from the ordinary democratic accountability that might otherwise correct them. Process and equity are not competing values; the question is whether both are being honored.

How we build The Lens

A hairdryer used to forge Nvidia serial numbers, a party balloon gas threatening to shut down the AI boom, and a cholesterol pill that could save more lives than any missile fired this month — buried on page twelve. The week's most reliable institution turned out to be a San Francisco jury, which is either reassuring or the most damning thing you can say about 2026. Stay sharp.

If someone you know is still getting their news from a CBS Radio top-of-hour update — forward them this before the signal goes dead.

• An AI-designed burger beat the Big Mac in blind taste tests — the real story is what it means for food R&D. Read → An AI Designed a Burger That Beat the Big Mac
• The Education Department quietly offered struggling colleges a lifeline — the fine print matters. Read → The Education Department Just Offered Struggling Colleges a Lifeline